How to read psychedelic evidence without being sold
Trials can be real and still be small, short, poorly blinded, or unready for the life you actually live.
Psychedelic science is not a rumor. There are randomized trials, neuroimaging studies, and serious disagreements among good researchers. The problem for a public reader is translation. A positive headline can hide a 30-person study, a waiting-list control, functional unblinding, or a follow-up measured in weeks.
A short field guide
- N: how many people, and were they like you (veteran status, severity, comorbidities, medicines)?
- Control: placebo, low dose, waiting list, or gold-standard therapy? Waiting lists inflate effects.
- Blinding: could participants and therapists tell who got the drug? In psychedelic trials, they often can.
- Duration: is the primary endpoint at 4 weeks or 12 months? Relapse and delayed harm live in the long tail.
- Harms: suicidal ideation, cardiovascular events, abuse liability, and dropouts — not only “mystical experience” scores.
- Sponsor and setting: academic trial, company program, or retreat brochure citing a trial it did not run.
What is relatively better established
Ketamine (and esketamine in specific clinical pathways) has a more mature medical footprint than classic psychedelics, with its own risks and a need for structured follow-up. Psilocybin and MDMA have generated encouraging signals in depression, end-of-life distress, and PTSD under tightly protocolized psychotherapy — and they have also generated regulatory caution, manufacturing and conduct controversies, and the ordinary failure of some programs to replicate early glow.
Ibogaine research, including intensive cardiac-monitored protocols, remains specialized and high-risk. Classic plant ceremonies are culturally serious practices; they are not interchangeable with FDA-style evidence, and borrowing their aesthetics is not the same as inheriting their safeguards.
We will keep a journal club for this kind of reading. You do not need a statistics degree. You need patience, and a refusal to outsource your judgment to either a skeptic’s sneer or a convert’s certainty.